［原著論文］
Suzuki Y, Tajiri M, Sugimoto A, Orime N, Hayashi T, Egawa J, Sugai T, Inoue
Y, Someya T: Sex differences in the effect of atomoxetine on the QT interval
in adult patients with attention-deficit hyperactivity disorder. J Clin
Psychopharmacol 37(1): 27-31, 2017.
Kushima I, Aleksic B, Nakatochi M, Shimamura T, Shiino T, Yoshimi A, Kimura
H, Takasaki Y, Wang C, Xing J, Ishizuka K, Oya-Ito T, Nakamura Y, Arioka
Y, Maeda T, Yamamoto M, Yoshida M, Noma H, Hamada S, Morikawa M, Uno Y,
Okada T, Iidaka T, Iritani S, Yamamoto T, Miyashita M, Kobori A, Arai M,
Itokawa M, Cheng MC, Chuang YA, Chen CH, Suzuki M, Takahashi T, Hashimoto
R, Yamamori H, Yasuda Y, Watanabe Y, Nunokawa A, Someya T, Ikeda M, Toyota
T, Yoshikawa T, Numata S, Ohmori T, Kunimoto S, Mori D, Iwata N, Ozaki
N: High-resolution copy number variation analysis of schizophrenia in Japan.
Mol Psychiatry 22(3): 430-440, 2017.
Watanabe J, Fukui N, Suzuki Y, Sugai T, Ono S, Tsuneyama N, Saito M, Tajiri
M, Someya T: Effect of GWAS-identified genetic variants on maximum QT interval
in patients with schizophrenia receiving antipsychotic agents: A 24-hour
Holter ECG study. J Clin Psychopharmacology 37(4): 452-455, 2017.
Ishizuka K, Fujita Y, Kawabata T, Kimura H, Iwayama Y, Inada T, Okahisa
Y, Egawa J, Usami M, Kushima I, Uno Y, Okada T, Ikeda M, Aleksic B, Mori
D, Someya T, Yoshikawa T, Iwata N, Nakamura H, Yamashita T, Ozaki N: Rare
genetic variants in CX3CR1 and their contribution to the increased risk
of schizophrenia and autism spectrum disorders. Transl Psychiatry 7(8):
e1184, 2017.
Hoya S, Watanabe Y, Hishimoto A, Nunokawa A, Inoue E, Igeta H, Otsuka I,
Shibuya M, Egawa J, Sora I, Someya T: Rare FBXO18 variations and risk of
schizophrenia: Whole-exome sequencing in two parent-affected offspring
trios followed by resequencing and case-control studies. Psychiatry Clin
Neurosci 71(8): 562-568, 2017.
Hoya S, Watanabe Y, Hishimoto A, Nunokawa A, Kaneko N, Muratake T, Shinmyo
N, Okuda I, Okuda S, Inoue E, Igeta H, Shibuya M, Egawa J, Orime N, Sora
I, Someya T: Rare PDCD11 variations are not associated with risk of schizophrenia
in Japan. Psychiatry Clin Neurosci 71(11): 780-788, 2017.
Orime N, Suzuki Y, Someya T: Survey on the management of physical risks
induced by psychotropic agents in Japan. Clin Neuropsychopharmacol Ther
8: 42-46, 2017.
Nishiura K, Ichikawa-Tomikawa N, Sugimoto K, Kunii Y, Kashiwagi K, Tanaka
M, Yokoyama Y, Hino M, Sugino T, Yabe H, Takahashi H, Kakita A, Imura T,
Chiba H: PKA activation and endothelial claudin-5 breakdown in the schizophrenic
prefrontal cortex. Oncotarget 8(55): 93382-93391, 2017.
Shichiri K, Tachibana A, Abe H, Kunizuka T, Yoshida Y, Tomiyama C, Watanabe
M: Characteristic changes defined via comparison of the big-five personalities
in Japanese university freshmen from years 2000 to 2016. Health 9: 1348-1354,
2017.
